What practice is necessary to ensure compliance with GPO purchasing rules?

Documenting non-covered drug policies is essential for compliance with Group Purchasing Organization (GPO) purchasing rules because it establishes clear guidelines on which drugs are not covered under the 340B Program. This documentation helps organizations ensure that they do not unintentionally violate GPO regulations, which prohibit the use of 340B drugs in the purchase of certain medications.

Having a solid understanding of which drugs are considered non-covered allows an organization to make informed purchasing decisions. It also serves as a critical reference during compliance audits, demonstrating that the organization has identified and accounted for drugs that do not qualify under the specific guidelines of the 340B Program.

While changes in suppliers, incorporation of private label products, or periodic audits have their own importance in various aspects of organizational operations, they do not directly address the specific regulatory requirements regarding GPO purchasing rules. Thus, good documentation of non-covered drugs is crucial for maintaining compliance and safeguarding the integrity of the 340B Program.